Hot Features
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the b... Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.06 | -1.1214953271 | 5.35 | 5.53 | 4.705 | 1222256 | 5.16480631 | CS |
| 4 | 0.48 | 9.97920997921 | 4.81 | 6.15 | 4.43 | 1477590 | 5.18730113 | CS |
| 12 | 1.11 | 26.5550239234 | 4.18 | 6.15 | 2.62 | 1396508 | 4.47346515 | CS |
| 26 | 0.52 | 10.9014675052 | 4.77 | 6.15 | 2.62 | 960761 | 4.55736765 | CS |
| 52 | 1.49 | 39.2105263158 | 3.8 | 6.15 | 2 | 1112551 | 3.90443619 | CS |
| 156 | -1.46 | -21.6296296296 | 6.75 | 6.87 | 1.84 | 465431 | 3.93763057 | CS |
| 260 | -3.46 | -39.5428571429 | 8.75 | 10.3 | 1.84 | 320483 | 4.29610218 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.